Artikel 233

Download as pdf or txt
Download as pdf or txt
You are on page 1of 9

Open Access Case

Report DOI: 10.7759/cureus.41142

A Case Report on Ambiguous Genitalia: A


Diagnostic, Therapeutic, and Cosmetic Challenge
Review began 06/17/2023
Mukta Agarwal 1 , Shivangni Sinha 2 , Sarsij Sharma 3 , Smita Singh 4 , Siddhant Roy 5
Review ended 06/25/2023
Published 06/29/2023 1. Obstetrics and Gynaecology, AII India Institute of Medical Sciences, Patna, Patna, IND 2. Obstetrics and
© Copyright 2023 Gynaecology, All India Institute of Medical Sciences, Patna, Patna, IND 3. Burns and Plastic Surgery, All India Institute
Agarwal et al. This is an open access article of Medical Sciences, Patna, Patna, IND 4. Obstetrics and Gynecology, AII India Institute of Medical Sciences, Patna,
distributed under the terms of the Creative Patna, IND 5. Urology, All India Institute of Medical Sciences, Raipur, Raipur, IND
Commons Attribution License CC-BY 4.0.,
which permits unrestricted use, distribution,
Corresponding author: Shivangni Sinha, justsinha@gmail.com
and reproduction in any medium, provided
the original author and source are credited.

Abstract
Ambiguous genitalia is a matter of concern and needs thorough evaluation and treatment. Gonadectomy
becomes a potentially lifesaving procedure in patients with partial androgen insensitivity due to the
increased risk of malignancy if left undiagnosed.

We present a case report of two patients in their late 20s and 30s, raised as girls, who came with complaints
of primary amenorrhea with ambiguous genitalia. Both patients had features of masculinization. Her MRI
revealed an absent uterus, cervix, upper 2/3 of the vagina, and ovaries, with the presence of bilateral
testicles. She was diagnosed with partial androgen insensitivity syndrome. The first patient underwent
bilateral gonadectomy with hernia repair and nerve-sparing reduction clitoroplasty with labioplasty. She is
under close follow-up with a further plan for augmentation mammoplasty. The second patient, however,
refused clitoroplasty and underwent bilateral gonadectomy.

Androgen insensitivity syndrome is an X-linked inheritance with a mutation in the AR gene. It consists of a
spectrum of conditions ranging from complete insensitivity to less insensitivity towards testosterone, which
results in a complete, partial, and mild form of androgen insensitivity syndrome. Studies have been done on
cosmetic outcomes after genitoplasty in children with genital atypicalities, which showed significant
improvement (p<0.001) and no difference in ratings by parents and surgeons.

Surgeries done on patients with partial androgen insensitivity syndrome are not only lifesaving procedures,
but with reasonable reassurance, these aesthetic surgeries help people live a life that otherwise would have
been genetically compromised.

Categories: Genetics, Obstetrics/Gynecology, Public Health


Keywords: ambiguous genitalia, aesthetic surgery, prophylactic gonadectomy, genitoplasty, : partial androgen
insensitivity syndrome

Introduction
Living with a rare disease is itself a challenge and a continuing stigma in this present world. Ambiguous
genitalia belongs to one such spectrum with a varied presentation, making its diagnosis difficult. It also
stands as a therapeutic dilemma and a challenge to clinicians. It is a congenital condition caused by atypical
development in chromosomal, gonadal, and phenotypic sex expression. External sex organs may differ from
internal sex organs or genetic sex. It is a sexual development condition. Usually, ambiguous genitalia is
visible at or shortly after birth, which can be quite upsetting for families. The sex organs of men and women
develop from the same tissue. The presence or absence of male hormones determines whether this tissue
develops into male or female organs. In a genetically male fetus, a lack or shortage of male hormones can
result in ambiguous genitalia, whereas exposure to male hormones during development results in
ambiguous genitalia in a genetically female fetus. Other reasons are genetic mutation, chromosomal
abnormalities, and enzymatic deficiency. Family history may be a factor in the development of ambiguous
genitalia because many sex development disorders are the result of inherited genetic anomalies.

We present a case report of two patients raised as girls with features of masculinization, primary
amenorrhea, and ambiguous genitalia.

Case Presentation
Case report 1
A 20-year-old woman presented at our OBG Outpatient Department three months ago with complaints of
primary amenorrhea and a lump palpable in the inguinal area. She was seventh in birth order and had no
notable family background. Patients and family members had previously failed to seek medical guidance.

How to cite this article


Agarwal M, Sinha S, Sharma S, et al. (June 29, 2023) A Case Report on Ambiguous Genitalia: A Diagnostic, Therapeutic, and Cosmetic Challenge.
Cureus 15(6): e41142. DOI 10.7759/cureus.41142
On examination, her height was 161 cm, her weight was 65 kg, and her BMI was 25.07 kg/m 2. She had a
male-type body contour with hirsutism (Ferriman-Gallwey Score: 19). Her breast tissues were not developed
(Tanner’s stage 2), and axillary hair was present with pubic hair developed to Tanner’s stage 4. In the
abdomen, bilateral lumps were palpable in the inguinal region. On local examination, there was
clitoromegaly (6 cm on the phall-o-meter), and a urethral opening 1 cm below the clitoris was seen. Both
labia majora and minora were well formed, with a blind vagina of 3 cm. Per-rectally, the uterus was not
palpable.

Her testosterone levels were high: 196.6 ng/dL (typical adult male 200-800 ng/dL, adult female 20-80 ng/dL).
Her serum LH (34.2 mIU/ml; normal range: 21.9-56.6 IU/mL) and FSH (25.9 mIU/ml; normal range: 4-25 IU/L)
levels were elevated, but she had a low level of estradiol (40.8 pg/mL; normal range: 30-400 pg/mL).
However, the levels of dehydroepiandrosterone sulfate (DHEAS; 166.4 g/dL, normal range: 145-395),
androstenedione (1.05 ng/mL, normal range: 0.7-3.1 ng/mL), 17-hydroxyprogesterone (0.60 ng/mL, normal
range: 2.8 ng/mL), and cortisol (14.6 mcg/dL; normal range: 6-23 mcg/dL) were within the standard range.

An MRI revealed that there was no uterus, cervix, upper 2/3rd vagina, or ovaries, but there were bilateral
testicles with seminal vesicles, vas deference, and a little prostrate-like tissue at the bladder base. There
were no numerical or structural irregularities in the karyotype, which was 46XY.

Following detailed counselling, the patient underwent bilateral gonadectomy with hernia repair and nerve-
sparing reduction clitoroplasty. Per-operatively, bilateral gonads were identified, and the total clitoral
length was 9.5 cm. Histological examination showed Leydig cell proliferation and atrophic seminiferous
tubules with no evidence of any ovarian tissue, hence confirming the gonads as testis. The diagnosis of
partial androgen insensitivity was confirmed. Her post-operative stay was uneventful (Figures 1-4).

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 2 of 9


FIGURE 1: The physical characteristics of the patient illustrate the male
type of body contour.
Self-ownership declared.

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 3 of 9


FIGURE 2: Per-operative findings suggestive of bilateral gonads and
clitoromegaly.
Self-ownership declared.

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 4 of 9


FIGURE 3: Per-operative picture illustrating clitoromegaly of
approximately 9.5 cm.
Self-ownership declared.

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 5 of 9


FIGURE 4: Post-operative day 7.
Self-ownership declared.

The repeat hormonal profile after a month showed testosterone level <10ng/dl. The patient was kept on
hormonal therapy during her follow-up and planned for augmentation Mammoplasty eventually.

Case report 2
Another 32-year-old married nulligravida appeared in our outpatient department with a six-month history
of bilateral inguinal area edoema and pain. She had no notable family history. The patient had primary
amenorrhea but had failed to follow up.

Her height was 170 cm, her weight was 62 kg, and her BMI was 21.4 kg/m 2. Tanner stage 4 breast
development: axillary hair is present with pubic hair development (Tanner stage 4). On examination, there
was bilateral firm tender swelling (6 cm × 4 cm and 4 cm × 4 cm) with a positive cough impulse. She had
clitoromegaly of about 3 cm (on the phall-o-meter) with otherwise well-developed female external genitalia
and an 8 cm blind vaginal pouch. Her ultrasound revealed non-existent ovaries, uterus, cervix, and
testicular-like abnormalities in the inguinal region. Serum testosterone level was 178 ng/dL (typical adult
male 200-800 ng/dL, adult female 20-80 ng/dL); other hormone levels were within normal limits. The
karyotype was 46XY, with no structural/numerical aberrations, confirming the diagnosis of partial androgen
insensitivity. High cord ligation with bilateral orchiectomy was done with a refusal to further any cosmetic
surgical intervention. Histopathological examination revealed a mixed germ cell testicular tumour (Figures
5-6).

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 6 of 9


FIGURE 5: Pre-operative physical characteristics show inguinal hernia
with clitoromegaly of 3.0 cm.
Self-ownership declared.

FIGURE 6: Histopathological slide shows mixed germ cell tumour with


atrophied seminiferous tubules.
Self-ownership declared.

Discussion
Androgen insensitivity syndrome is an X-linked inheritance that results in a person who is genetically male

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 7 of 9


(46 XY) but resistant to male hormones (called androgens) and thus has some of the physical attributes of a
woman with the genetic composition of a man, with an incidence of one in 130,000 births [1]. It includes a
range of conditions ranging from complete to partial insensitivity to testosterone, resulting in complete,
partial, and mild forms. The phenotype varies based on the function of the residual androgen receptor,
ranging from severe under-masculinization with female-like external genitalia to male-appearing genitalia:
complete androgen insensitivity syndrome (CAIS) with predominantly female external genitalia
(testosterone has no influence on sexual development), partial androgen insensitivity syndrome (PAIS) with
predominantly male/female or ambiguous genitalia (partial response to testosterone), and mild androgen
insensitivity syndrome (MAIS) with predominantly male external genitalia. Ambiguity in genitalia is
normally recognized at birth; nevertheless, if not diagnosed, some children are raised as males with a small
phallus and some breast tissue at puberty. Unlike in our situation, some children with clitoromegaly with or
without hypospadias may be raised as girls.

Bilateral (39%) or unilateral (28%) inguinal hernia, a positive family history (21%), a mismatch between
amniocentesis-karyotype and phenotypic sex (6%), and primary amenorrhea (6%) are some of the clinical
manifestations [2]. In a study conducted in Finland [3], vaginal length was proven to be a valuable clinical
tool in screening prepubertal girls for androgen insensitivity syndrome. Early detection is particularly
critical since prompt treatments can prevent the development of gonadal cancer. However, because there are
no clear and sensitive indicators for early diagnosis of pre-malignant alterations in the gonads, early
gonadectomy is still suggested in high-risk populations [4]. Once puberty is reached, preventive
gonadectomy and ongoing hormone replacement are indicated to maintain bone health [5].

Surgical and non-surgical aesthetic gynaecologic procedures have redefined the notion of beauty [6]. Gender
is a concept of society that is frequently predicated on the idea of a biological binary, but even the best
scientific tests cannot - and arguably should not - exactly divide all people into "male" and "female" sexes.
We underestimate the diversity of sexuality, as external genitalia, hormone profiles, reproductive anatomy,
or chromosomal structure cannot properly characterize it [7]. Studies of cosmetic outcomes after
genitoplasty in children with genital atypia showed significant improvement (p<0.001) and no difference in
ratings was seen between parents and surgeons [8]. However, satisfaction with post-operative cosmesis does
not necessarily equate with functional outcomes later in life.

Individuals who live with a rare disease can face challenges that can be overwhelming. These challenges may
include limited information about the disease and the treatment, adjustment to daily activities, social
isolation, a wide range of emotions, and economic difficulties. A multidisciplinary team with a psychiatrist
and a gynaecologist is required who could counsel about the condition and its prevalence, sexual identity,
inability to have childbearing capacity, the need for surgery, regular postoperative follow-up, and hormone
supplementation.

Limitations
The patients in the study were consenting adults when they underwent genitoplasty, thus eliminating the
factor that makes these surgeries controversial for patients with differences in sex development (DSD): that
they are almost always too young to consent to the surgeries that shape their bodies into conformity with
the gender assigned at birth and the stereotypical sexualities associated with those genders.

Conclusions
Surgeries done on patients with partial androgen insensitivity syndrome are not only lifesaving procedures
but also help them live life on their own terms. It is a matter of great work and research, as gonadectomy
after puberty is still controversial. Also, difficulties in determining the absolute malignancy risk, difficulties
with hormone therapy, and a lack of studies supporting different protocols need attention and focus.

Additional Information
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In
compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services
info: All authors have declared that no financial support was received from any organization for the
submitted work. Financial relationships: All authors have declared that they have no financial
relationships at present or within the previous three years with any organizations that might have an
interest in the submitted work. Other relationships: All authors have declared that there are no other
relationships or activities that could appear to have influenced the submitted work.

Acknowledgements
Dr Mukta and Dr Shivangni contributed equally to the work and should be considered co-first authors.

References

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 8 of 9


1. Bangsbøll S, Qvist I, Lebech PE, Lewinsky M: Testicular feminization syndrome and associated gonadal
tumors in Denmark. Acta Obstet Gynecol Scand. 1992, 71:63-6. 10.3109/00016349209007950
2. Ahmed SF, Cheng A, Dovey L, et al.: Phenotypic features, androgen receptor binding, and mutational
analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab. 2000,
85:658-65. 10.1210/jcem.85.2.6337
3. Hurme T, Lahdes-Vasama T, Makela E, Iber T, Toppari J: Clinical findings in prepubertal girls with inguinal
hernia with special reference to the diagnosis of androgen insensitivity syndrome. Scand J Urol Nephrol.
2009, 43:42-6. 10.1080/00365590802299247
4. Döhnert U, Wünsch L, Hiort O: Gonadectomy in complete androgen insensitivity syndrome: why and when? .
Sex Dev. 2017, 11:171-4. 10.1159/000478082
5. Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J: Androgen insensitivity
syndrome. Lancet. 2012, 380:1419-28. 10.1016/S0140-6736(12)60071-3
6. Güneş A, Alinsod RM: A mini-review of aesthetic gynecology and leading gynecology associations'
approaches to this issue. Turk J Obstet Gynecol. 2018, 15:105-11. 10.4274/tjod.33407
7. Davis G, Preves S: Intersex and the social construction of sex . ASA. 2017, 16:80. 10.1177/1536504217696082
8. Nokoff NJ, Palmer B, Mullins AJ, et al.: Prospective assessment of cosmesis before and after genital surgery .
J Pediatr Urol. 2017, 13:28.e1-6. 10.1016/j.jpurol.2016.08.017

2023 Agarwal et al. Cureus 15(6): e41142. DOI 10.7759/cureus.41142 9 of 9

You might also like